Company intelligence / Profile preview

Gene X-Press

Las Condes, Santiago Metropolitan Region, Chilegenexpress.cl ↗
Ownership
Private
Development stage
Other
01

Overview

Gene X-Press is a Chilean distributor founded in 2001 that supplies products for scientific and biotechnological research. The company focuses on providing high-quality laboratory analysis and measurement technology products—including those used in antibody research and PCR—to the Chilean market. It does not develop its own therapeutic pipeline but plays an important role as a supplier for life science laboratories.

Modalities
AntibodyMonoclonal antibodyAntibody-drug conjugatePCR-related reagents and technologies
Industry
Non-Drug Biotech

Beyond the preview

Go deeper on Gene X-Press.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gene X-Press.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call